Home / Inspections / 814051

FDA Inspection 814051 — Galephar Pharmaceutical Research Inc.

Galephar Pharmaceutical Research Inc. — FEI 3008206797

The FDA completed an inspection of Galephar Pharmaceutical Research Inc. on January 15, 2013 in Humacao, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 15, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Humacao, PR (United States)

Facility

Other inspections at this facility

  • 1273815 (NAI Thu Jun 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108270 (VAI Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931265 (VAI Thu Jun 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 776879 (VAI Mon May 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources